Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITCA 650 versus sitagliptin add-on to metformin in type 2 diabetes
2012-002117-19Phase 3Completed
- Sponsor
- Intarcia Therapeutics
- Start
- Sep 2012
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ITCA 650, sitagliptin, metformin in type 2 diabetes mellitus (T2DM), sponsored by Intarcia Therapeutics. Started Sep 2012; status: completed.
02
Drugs
ITCA 650sitagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-002117-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002117-19.